CATALAYER NEWS
A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO
Source: Bloomberg Markets · 2026-07-30
Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector.
MORE FROM BLOOMBERG MARKETS
Warsh Presser ‘A Little Bit Rocky,’ Says James Bullard
2026-07-30
US GDP Grows Less-Than-Expected 1.5% in Second Quarter
2026-07-30
BOE's Lombardelli Says Holding Rates Was Right Thing to Do
2026-07-30
Indian Air Force Seeks Local Makers as Wars Disrupt Supplies
2026-07-30
Bailey Says BOE Decided to Keep Rates at 3.75% in July
2026-07-30
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets